scispace - formally typeset
Journal ArticleDOI

Characterization of carbapenem-resistant Gram-negative bacteria from Tamil Nadu

Reads0
Chats0
TLDR
The results confirm the dissemination of NDM and emergence of OXA-181 beta-lactamase among Gram-negative bacteria in South India and showed the emergence of N DM producer in clinical isolates of E. hormaechei and P. rettgeri in India.
Abstract
Carbapenem resistance is disseminating worldwide among Gram-negative bacteria The aim of this study was to identify carbapenem-resistance level and to determine the mechanism of carbapenem resistance among clinical isolates from two centres in Tamil Nadu In the present study, a total of 93 Gram-negative isolates, which is found to be resistant to carbapenem by disk diffusion test in two centres, were included All isolates are identified at species level by 16S rRNA sequencing Minimal inhibitory concentrations (MICs) of isolates for Meropenem were tested by agar dilution method Presence of blaOXA, blaNDM, blaVIM, blaIMP and blaKPC genes was tested by PCR in all isolates Amplicons were sequenced for confirmation of the genes Among 93 isolates, 48 (%52) were Escherichia coli, 10 (%11) Klebsiella pneumoniae, nine (%10) Pseudomonas aeruginosa Minimal inhibitory concentration results showed that of 93 suspected carbapenem-resistant isolates, 27 had meropenem MICs ≥ 2 μg/ml The MIC range, MIC50 and MIC9

read more

Citations
More filters
Journal ArticleDOI

The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model

TL;DR: The data shows that although in vitro studies showed high infectivity of phages, for in vivo models multiple phage doses were required for effective treatment.
Journal ArticleDOI

First literature review of carbapenem-resistant Providencia.

TL;DR: Patients' characteristics, resistance mechanisms, treatment and infection control measures of carbapenem-resistant Providencia species in the literature are described.
Journal ArticleDOI

Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases.

TL;DR: Relebactam did potentiate imipenem against ESBL-producing P. aeruginosa, but this potentiation was generally insufficient to reduce imipanem MICs to the clinical range, just as for Enterobacterales.
References
More filters
Journal ArticleDOI

Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India

TL;DR: A Swedish patient of Indian origin traveled to New Delhi, India, and acquired a urinary tract infection caused by a carbapenem-resistant Klebsiella pneumoniae strain that typed to the sequence type 14 complex, showing broad resistance carried on these plasmids.
Journal ArticleDOI

Targeting virulence: a new paradigm for antimicrobial therapy

TL;DR: It is proposed that in addition to targeting virulence, new antimicrobial development strategies should be expanded to include targeting bacterial gene functions that are essential for in vivo viability.
Related Papers (5)